To support six research projects in fields from neuroscience to food safety and Arctic ecosystems
Category:
Published on: 15 Apr 2016
CREATE project to prepare graduates for high-skills work in surgical-devices industry
A team led by McGill University professor Jake Barralet will receive $1.65 million from the Natural Sciences and Engineering Research Council of Canada to provide nearly 90 students with cross-disciplinary training to prepare them for high-skill jobs in the surgical devices industry.
Published on: 14 Apr 2016
By Fergus Grieve, McGill Newsroom
Depression, metabolic factors combine to boost risk of developing diabetes, study finds
Depression may compound the risk of developing type 2 diabetes in people with early warning signs of metabolic disease, according to researchers from McGill University, l'Université de Montréal, the Institut de recherches cliniques de Montréal and the University of Calgary.
Published on: 12 Apr 2016
Published on: 11 Apr 2016
By Tod Hoffman, Lady Davis Institute
Research reveals that even a tiny mutation can allow the HIV virus to become resistant to therapies using the CRISPR/Cas9 gene-editing platform
Published on: 8 Apr 2016
McGill University Health Centre
RI-MUHC will lead an innovative pan-Canadian network that aims to improve life outcomes for children with brain-based development disabilities
RI-MUHC will lead an innovative pan-Canadian network that aims to improve life outcomes for children with brain-based development disabilities
Category:
Published on: 31 Mar 2016
McGill, UCLA study of low- and middle-income countries shows paid maternity leave policies could help prevent infant deaths
For each additional month of paid maternity leave offered in low- and middle-income countries (LMICs), infant mortality is reduced by 13%, according to a new study by researchers from McGill University and UCLA Fielding School of Public Health.
Published on: 30 Mar 2016
McGill Newsroom
Canadian drug safety network provides reassuring evidence regarding risk of heart failure of anti-diabetes medications
Incretin-based drugs, a type of medication used to treat type 2 diabetes, do not increase the risk of being hospitalized for heart failure relative to commonly used combinations of oral anti-diabetic drugs, according to a new study published in the New England Journal of Medicine.
Published on: 24 Mar 2016
By Julie Robert, McGill University Health Centre
Millions of people today take statins to help lower their cholesterol level.
Category:
Published on: 11 Mar 2016
MONTREAL FEBRUARY 22, 2016
Published on: 9 Mar 2016
By Maya-Olivia Eyssen, Montreal Neurological Institute and Hospital
Montreal high school students to take part in brain quiz.
Published on: 9 Mar 2016
By Julie Robert, McGill University Health Centre
Hip fractures are one of the most common injuries sustained by the elderly population following a fall.
Published on: 4 Mar 2016
By Chris Chipello, McGill Newsroom
Surprisingly complex interactions between neurotransmitter receptors and other key proteins help explain the brain’s ability to process information with lightning speed, according to a new study.
Published on: 25 Feb 2016
By Tod Hoffman, Lady Davis Institute for Medical Research
The use of incretin-based drugs is not associated with an increased risk of pancreatic cancer in patients with type 2 diabetes, according to a study published in the latest issue of the British Medical Journal (BMJ).
The research was conducted by the Canadian Network for Observational Drug Effect Studies (CNODES), which used the health records of almost 1 million patients with types 2 diabetes.
Published on: 22 Feb 2016
By Julie Robert, McGill University Health Centre
A research team, led by the Research Institute of the McGill University Health Centre (RI-MUHC) in Montreal, has broken new ground in our understanding of the complex functioning of the brain.
Category:
Published on: 18 Feb 2016
Pages
